Abivax shares soar 23% as media report reignites M&A chatter
The acquisition interest from Eli Lilly signifies potential growth for ABVX. Historical examples show stocks often rise on acquisition rumors, increasing investor confidence.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The acquisition interest from Eli Lilly signifies potential growth for ABVX. Historical examples show stocks often rise on acquisition rumors, increasing investor confidence.
What happened, with direct paths to the underlying reporting
ABVX shares rose 23% after news of Eli Lilly's acquisition interest. The stock exceeded 121 euros, indicating strong market response.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.